Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design.

medRxiv : the preprint server for health sciences·2023
Same author

Hybrid palliation versus nonhybrid management for a multi-institutional cohort of infants with critical left heart obstruction.

The Journal of thoracic and cardiovascular surgery·2023
Same author

Patient-Reported Outcomes After Tetralogy of Fallot Repair.

Journal of the American College of Cardiology·2023
Same author

Endothelial Function in Youth With Bipolar Disorder: Preliminary Evidence for Mood Polarity Differences.

The Journal of clinical psychiatry·2023
Same author

Looking Backward and Forward: The Cardiovascular Complications of COVID-19.

The Canadian journal of cardiology·2023
Same author

Imaging the delayed complications of childhood Kawasaki disease.

F1000Research·2023

Related Experiment Video

Updated: May 31, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Long-term tricuspid valve function after Norwood operation.

Maryam Elmi1, Edward J Hickey, William G Williams

  • 1Division of Cardiology, Department of Pediatrics, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada.

The Journal of Thoracic and Cardiovascular Surgery
|June 28, 2011
PubMed
Summary
This summary is machine-generated.

Up to 25% of survivors of Norwood palliation for hypoplastic left heart syndrome require tricuspid valve surgery. Mitral atresia and longer ischemic times during Norwood surgery are key risk factors for intervention.

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation
08:43

Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation

Published on: March 17, 2023

Related Experiment Videos

Last Updated: May 31, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation
08:43

Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation

Published on: March 17, 2023

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Echocardiography

Background:

  • Long-term outcomes after Norwood palliation depend on systemic tricuspid valve function.
  • Tricuspid valve performance is critical for patients with a systemic right ventricle.

Purpose of the Study:

  • To identify factors associated with tricuspid valve intervention after Norwood stage 1 palliation.
  • To evaluate the impact of tricuspid valve intervention on survival and right ventricular function.

Main Methods:

  • Retrospective analysis of 219 children undergoing Norwood stage 1 palliation (1990-2007).
  • Competing risks analysis for tricuspid valve intervention and death.
  • Time-related outcome analysis of 2705 echocardiogram reports using repeated measures adjustment.
  • Bootstrapping for variable selection.

Main Results:

  • Approximately 25% of survivors required tricuspid valve intervention (27 repairs, 3 replacements).
  • Risk factors included mitral atresia, longer myocardial ischemic time during Norwood, and moderate/severe tricuspid regurgitation post-Norwood.
  • Tricuspid valve intervention did not compromise survival or worsen right ventricular function.
  • A late hazard for intervention emerged 10-15 years post-Norwood.

Conclusions:

  • Tricuspid valve surgery is common and necessary in up to 25% of survivors of single ventricle palliation.
  • Mitral atresia and prolonged myocardial ischemia during Norwood are significant risks.
  • While tricuspid repair preserves RV function, the late risk of intervention warrants further investigation for long-term implications.